![](/img/cover-not-exists.png)
Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies
Nelson, M.R., Elion, R.A., Cohen, C.J., Mills, A., Hodder, S.L., Segal-Maurer, S., Bloch, M., Garner, W., Guyer, B., Williams, S., Chuck, S.K., Vanveggel, S., Deckx, H., Stevens, M.Volume:
14
Language:
english
Journal:
HIV Clinical Trials
DOI:
10.1310/hct1403-81
Date:
May, 2013
File:
PDF, 461 KB
english, 2013